New quality requirements for tobacco products
European Pharmaceutical Review
JUNE 8, 2023
9″ It will be interesting to see whether FDA tries to control carcinogenic TSNAs in tobacco products using an acceptable intake (AI) strategy, aligned with approaches applied to medicinal products for nitrosamines. He is currently a CMC consultant with an interest in impurities and safety‑based limits. 2020; 2020: 1–7.
59 
Let's personalize your content